Affinity Asset Advisors, LLC Aclaris Therapeutics, Inc. Transaction History

Affinity Asset Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $476,192 - $663,827	36,434 Added 36.43%	136,434 $2.15 Million
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $2.92 Million - $5.38 Million	-300,000 Reduced 75.0%	100,000 $1.72 Million
Q4 2021 Feb 11, 2022	BUY	$12.27 - $18.49 $613,500 - $924,499	50,000 Added 14.29%	400,000 $5.82 Million
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $1 Million - $1.41 Million	75,000 Added 27.27%	350,000 $6.3 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $900,679 - $1.56 Million	52,733 Added 23.73%	275,000 $4.83 Million
Q1 2021 May 14, 2021	BUY	$5.86 - $27.73 $1.3 Million - $6.16 Million	222,267 New	222,267 $5.6 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.